Clinical Trial Update: Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a sirolimus-eluting, heparin-coated cobalt-chromium stent for de novo coronary artery lesions in small vessels completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting, heparin-coated CoCr stent

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED